Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'

Published 31/01/2023, 12:55
© Reuters.  Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
SYK
-
DVA
-
S1YK34
-

Benzinga - On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, you can find it in health care, it’s reasonably priced," specifically in biotech.

Shannon Saccocia of Boston Private said Stryker Corporation (NYSE: SYK) is a growth play in medical instruments and equipment. Procedures will "continue to accelerate," she added.

Don’t forget to check out our premarket coverage here.

Brian Brooks, Bitfury CEO, named Invesco DB US Dollar Index Bullish Fund (NYSE: UUP) as his final trade.

Joseph Terranova of Virtus Investment Partners said DaVita Inc. (NYSE: DVA) is trading at 11 times earnings and has 95% U.S. revenue exposure.

Check This Out: NVIDIA, Micron Technology Club And 2 Other Stocks Insiders Are Selling

Photo via Shutterstock.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.